Cyteir Therapeutics Ownership 2024 | Who Owns Cyteir Therapeutics Now?


OverviewForecastFinancialsChart

Institutional Ownership

57.38%

Insider Ownership

6.64%

Retail Ownership

35.98%

Institutional Holders

32.00

Cyteir Therapeutics Institutional Shareholders


Institutional Shareholders by % of Total Shares

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
NOVO HOLDINGS A/S11.17%7.45%3,940,413--112,892,832,000Mar 31, 2023
PUBLIC EMPLOYEES RETIREMENT SYSTEM OF OHIO9.03%0.00%3,183,697--46,000Mar 31, 2023
BML CAPITAL MANAGEMENT, LLC8.92%4.95%3,146,2963,146,296100.00%5,726,259,000Mar 31, 2023
OUP MANAGEMENT CO., LLC6.97%8.93%2,459,572--4,476,421,000Mar 31, 2023
FMR LLC6.39%0.00%2,252,331-656,045-22.56%4,099,242,000Mar 31, 2023
AVIDITY PARTNERS MANAGEMENT LP5.00%0.11%1,764,100-31,700-1.77%3,210,662,000Mar 31, 2023
NEWTYN MANAGEMENT, LLC2.70%0.34%952,947-67,053-6.57%1,734,364,000Mar 31, 2023
VANGUARD GROUP INC1.66%-584,783--1,064,305,000Mar 31, 2023
LAURION CAPITAL MANAGEMENT LP1.02%0.00%359,500--654,290,000Mar 31, 2023
RENAISSANCE TECHNOLOGIES LLC0.50%0.00%176,034-53,159-23.19%320,000Mar 31, 2023
ALDEBARAN CAPITAL, LLC0.43%0.28%151,239151,239100.00%275,255,000Mar 31, 2023
CAAS CAPITAL MANAGEMENT LP0.43%0.01%150,406-309,373-67.29%273,739,000Mar 31, 2023
EVERCORE WEALTH MANAGEMENT, LLC0.42%0.01%146,676--266,950,000Mar 31, 2023
MORGAN STANLEY0.35%-125,20394,931313.59%227,869,000Mar 31, 2023
GEODE CAPITAL MANAGEMENT, LLC0.34%-119,0321,9001.62%216,638,000Mar 31, 2023
RBF CAPITAL, LLC0.33%0.02%117,295-33,987-22.47%213,477,000Mar 31, 2023
TANG CAPITAL MANAGEMENT LLC0.28%0.03%100,000100,000100.00%182,000,000Mar 31, 2023
MILLENNIUM MANAGEMENT LLC0.24%0.00%83,776-95,590-53.29%152,000Mar 31, 2023
BLACKROCK INC.0.23%-81,2461,9022.40%147,868,000Mar 31, 2023
BRIDGEWAY CAPITAL MANAGEMENT, LLC0.20%0.00%69,584-50,000-41.81%126,643,000Mar 31, 2023

Cyteir Therapeutics's largest institutional shareholder is NOVO HOLDINGS A/S, holding 11.17% of the company's total share outstanding, currently valued at $112.89B. The top 10 institutional shareholders own together 53.35% of the company.

Institutional Shareholders by % of Total Assets

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
OUP MANAGEMENT CO., LLC6.97%8.93%2,459,572--4,476,421,000Mar 31, 2023
NOVO HOLDINGS A/S11.17%7.45%3,940,413--112,892,832,000Mar 31, 2023
BML CAPITAL MANAGEMENT, LLC8.92%4.95%3,146,2963,146,296100.00%5,726,259,000Mar 31, 2023
NEWTYN MANAGEMENT, LLC2.70%0.34%952,947-67,053-6.57%1,734,364,000Mar 31, 2023
ALDEBARAN CAPITAL, LLC0.43%0.28%151,239151,239100.00%275,255,000Mar 31, 2023
AVIDITY PARTNERS MANAGEMENT LP5.00%0.11%1,764,100-31,700-1.77%3,210,662,000Mar 31, 2023
MARQUETTE ASSET MANAGEMENT, LLC0.19%0.03%67,99067,990100.00%123,742,000Mar 31, 2023
TANG CAPITAL MANAGEMENT LLC0.28%0.03%100,000100,000100.00%182,000,000Mar 31, 2023
RBF CAPITAL, LLC0.33%0.02%117,295-33,987-22.47%213,477,000Mar 31, 2023
CAAS CAPITAL MANAGEMENT LP0.43%0.01%150,406-309,373-67.29%273,739,000Mar 31, 2023
CANNELL CAPITAL LLC0.06%0.01%19,684--35,825,000Mar 31, 2023
EVERCORE WEALTH MANAGEMENT, LLC0.42%0.01%146,676--266,950,000Mar 31, 2023
LAURION CAPITAL MANAGEMENT LP1.02%0.00%359,500--654,290,000Mar 31, 2023
BRIDGEWAY CAPITAL MANAGEMENT, LLC0.20%0.00%69,584-50,000-41.81%126,643,000Mar 31, 2023
ECOR1 CAPITAL, LLC0.12%0.00%43,82343,823100.00%79,758,000Mar 31, 2023
LINDBROOK CAPITAL, LLC0.01%0.00%2,006--3,651,000Mar 31, 2023
RENAISSANCE TECHNOLOGIES LLC0.50%0.00%176,034-53,159-23.19%320,000Mar 31, 2023
FMR LLC6.39%0.00%2,252,331-656,045-22.56%4,099,242,000Mar 31, 2023
PUBLIC EMPLOYEES RETIREMENT SYSTEM OF OHIO9.03%0.00%3,183,697--46,000Mar 31, 2023
TWO SIGMA ADVISERS, LP0.07%0.00%26,000--47,320,000Mar 31, 2023

The largest Cyteir Therapeutics shareholder by % of total assets is OUP MANAGEMENT CO., LLC. The company owns 2.46M shares of Cyteir Therapeutics (CYT), representing 8.93% of its total assets.

Institutional Buyers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
BML CAPITAL MANAGEMENT, LLC8.92%4.95%3,146,2963,146,296100.00%5,726,259,000Mar 31, 2023
ALDEBARAN CAPITAL, LLC0.43%0.28%151,239151,239100.00%275,255,000Mar 31, 2023
TANG CAPITAL MANAGEMENT LLC0.28%0.03%100,000100,000100.00%182,000,000Mar 31, 2023
MORGAN STANLEY0.35%-125,20394,931313.59%227,869,000Mar 31, 2023
MARQUETTE ASSET MANAGEMENT, LLC0.19%0.03%67,99067,990100.00%123,742,000Mar 31, 2023
ECOR1 CAPITAL, LLC0.12%0.00%43,82343,823100.00%79,758,000Mar 31, 2023
BANK OF AMERICA CORP /DE/0.19%-67,53942,722172.15%122,921,000Mar 31, 2023
UBS GROUP AG0.01%-4,8254,825100.00%8,782,000Mar 31, 2023
NORTHERN TRUST CORP0.05%-18,9844,07727.35%34,551,000Mar 31, 2023
BLACKROCK INC.0.23%-81,2461,9022.40%147,868,000Mar 31, 2023
GEODE CAPITAL MANAGEMENT, LLC0.34%-119,0321,9001.62%216,638,000Mar 31, 2023
FEDERATED HERMES, INC.0.00%-208208100.00%379,000Mar 31, 2023
WELLS FARGO & COMPANY/MN0.00%-9811.03%178,000Mar 31, 2023
JPMORGAN CHASE & CO0.00%-496--1,000,000Mar 31, 2023
STATE STREET CORP0.07%-23,853--43,412,000Mar 31, 2023
VANGUARD GROUP INC1.66%-584,783--1,064,305,000Mar 31, 2023
TWO SIGMA ADVISERS, LP0.07%0.00%26,000--47,320,000Mar 31, 2023
PUBLIC EMPLOYEES RETIREMENT SYSTEM OF OHIO9.03%0.00%3,183,697--46,000Mar 31, 2023
LINDBROOK CAPITAL, LLC0.01%0.00%2,006--3,651,000Mar 31, 2023
LAURION CAPITAL MANAGEMENT LP1.02%0.00%359,500--654,290,000Mar 31, 2023

As of Mar 31 2023, Cyteir Therapeutics's largest institutional buyer is BML CAPITAL MANAGEMENT, LLC. The company purchased 3.15M stocks of CYT, valued at $5.73B.

Institutional Sellers

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
BAKER BROS. ADVISORS LP----2,492,118-100.00%-Mar 31, 2023
FMR LLC6.39%0.00%2,252,331-656,045-22.56%4,099,242,000Mar 31, 2023
CAAS CAPITAL MANAGEMENT LP0.43%0.01%150,406-309,373-67.29%273,739,000Mar 31, 2023
MILLENNIUM MANAGEMENT LLC0.24%0.00%83,776-95,590-53.29%152,000Mar 31, 2023
NEWTYN MANAGEMENT, LLC2.70%0.34%952,947-67,053-6.57%1,734,364,000Mar 31, 2023
RENAISSANCE TECHNOLOGIES LLC0.50%0.00%176,034-53,159-23.19%320,000Mar 31, 2023
BRIDGEWAY CAPITAL MANAGEMENT, LLC0.20%0.00%69,584-50,000-41.81%126,643,000Mar 31, 2023
RBF CAPITAL, LLC0.33%0.02%117,295-33,987-22.47%213,477,000Mar 31, 2023
AVIDITY PARTNERS MANAGEMENT LP5.00%0.11%1,764,100-31,700-1.77%3,210,662,000Mar 31, 2023
ERGOTELES LLC----30,148-100.00%-Mar 31, 2023
CITADEL ADVISORS LLC----21,044-100.00%-Mar 31, 2023
INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC----14,400-100.00%-Mar 31, 2023
CITIGROUP INC----246-100.00%-Mar 31, 2023
OUP MANAGEMENT CO., LLC6.97%8.93%2,459,572--4,476,421,000Mar 31, 2023
NOVO HOLDINGS A/S11.17%7.45%3,940,413--112,892,832,000Mar 31, 2023
CANNELL CAPITAL LLC0.06%0.01%19,684--35,825,000Mar 31, 2023
EVERCORE WEALTH MANAGEMENT, LLC0.42%0.01%146,676--266,950,000Mar 31, 2023
LAURION CAPITAL MANAGEMENT LP1.02%0.00%359,500--654,290,000Mar 31, 2023
LINDBROOK CAPITAL, LLC0.01%0.00%2,006--3,651,000Mar 31, 2023
PUBLIC EMPLOYEES RETIREMENT SYSTEM OF OHIO9.03%0.00%3,183,697--46,000Mar 31, 2023

As of Mar 31 2023, Cyteir Therapeutics's biggest institutional seller is BAKER BROS. ADVISORS LP. The company sold -2.49M shares of CYT, valued at -.

Institutional New positions

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
BML CAPITAL MANAGEMENT, LLC8.92%4.95%3,146,2963,146,296100.00%5,726,259,000Mar 31, 2023
ALDEBARAN CAPITAL, LLC0.43%0.28%151,239151,239100.00%275,255,000Mar 31, 2023
TANG CAPITAL MANAGEMENT LLC0.28%0.03%100,000100,000100.00%182,000,000Mar 31, 2023
MARQUETTE ASSET MANAGEMENT, LLC0.19%0.03%67,99067,990100.00%123,742,000Mar 31, 2023
ECOR1 CAPITAL, LLC0.12%0.00%43,82343,823100.00%79,758,000Mar 31, 2023
UBS GROUP AG0.01%-4,8254,825100.00%8,782,000Mar 31, 2023
FEDERATED HERMES, INC.0.00%-208208100.00%379,000Mar 31, 2023

Cyteir Therapeutics's largest new institutional shareholder by number of shares is BML CAPITAL MANAGEMENT, LLC, purchased 3.15M shares, valued at $5.73B, as of undefined.

Institutional Sold Out

Name% Total Shares% Total AssetsCurrent SharesChange AmountChange %Market ValueDate
BAKER BROS. ADVISORS LP----2,492,118-100.00%-Mar 31, 2023
ERGOTELES LLC----30,148-100.00%-Mar 31, 2023
CITADEL ADVISORS LLC----21,044-100.00%-Mar 31, 2023
INTERNATIONAL ASSETS INVESTMENT MANAGEMENT, LLC----14,400-100.00%-Mar 31, 2023
CITIGROUP INC----246-100.00%-Mar 31, 2023

Cyteir Therapeutics's largest sold out institutional shareholder by shares sold is BAKER BROS. ADVISORS LP, sold -2.49M shares, valued at -, as of undefined.

Cyteir Therapeutics Mutual Fund Holders


Name% Total AssetsTotal SharesChange AmountChange %Date
VANGUARD VALLEY FORGE FUNDS1.42%696,189--Dec 31, 2023
SYNTAX ETF TRUST1.03%33,038-1,336-3.89%Dec 31, 2023
Humankind Benefit Corp0.63%13,9343,08928.48%Dec 31, 2023
Comstock Funds, Inc.0.47%10,000--Jan 31, 2024
SPECIAL OPPORTUNITIES FUND, INC.0.39%200,000--Dec 31, 2023
DEUTSCHE DWS INVESTMENTS VIT FUNDS0.35%153,186--Dec 31, 2023
Madison Covered Call & Equity Strategy Fund0.30%124,000--Dec 31, 2023
VANGUARD QUANTITATIVE FUNDS0.28%2,435,0001,468,100151.84%Dec 31, 2023
Collaborative Investment Series Trust0.23%39,828--Dec 31, 2023
VANGUARD INDEX FUNDS0.23%104,898,70815,560,00017.42%Dec 31, 2023
FIDELITY ADVISOR SERIES VII0.17%1,419,670--Jan 31, 2024
VANGUARD HORIZON FUNDS0.11%2,320,499672,66940.82%Dec 31, 2023
ETFis Series Trust I0.09%131,621--Jan 31, 2024
GABELLI EQUITY TRUST INC0.07%90,000--Dec 29, 2023
Calvert Variable Products, Inc.0.04%100,196--Dec 31, 2023
VARIABLE INSURANCE PRODUCTS FUND II0.04%523,5922,8930.56%Dec 31, 2023
RYDEX VARIABLE TRUST0.02%29,276-14,968-33.83%Dec 31, 2023
T. Rowe Price Index Trust, Inc.0.02%415,946--Feb 29, 2024
VANGUARD INSTITUTIONAL INDEX FUNDS0.02%683,760--Dec 31, 2023
VANGUARD TAX-MANAGED FUNDS0.02%7,882,034-217,866-2.69%Dec 31, 2023
THRIVENT SERIES FUND INC0.01%1,642,193-200,882-10.90%Dec 29, 2023
PRAXIS MUTUAL FUNDS0.01%162,73069,82075.15%Dec 31, 2023
BRIDGEWAY FUNDS INC0.01%32,800-36,784-52.86%Dec 29, 2023
PRUDENTIAL SERIES FUND0.01%1,066,568-20,450-1.88%Dec 29, 2023
Voya VARIABLE PORTFOLIOS INC0.01%403,5532,0950.52%Dec 31, 2023
STATE STREET VARIABLE INSURANCE SERIES FUNDS INC0.01%49,546-3,118-5.92%Dec 31, 2023
ALLIANZ VARIABLE INSURANCE PRODUCTS TRUST0.01%575,915-37,845-6.17%Dec 31, 2023
FIDELITY SECURITIES FUND0.01%826,758--Jan 31, 2024
FIDELITY SELECT PORTFOLIOS0.01%451,123--Feb 29, 2024
RYDEX SERIES FUNDS0.01%24,535-19,769-44.62%Dec 31, 2023
MUTUAL OF AMERICA INVESTMENT CORP0.00%176,5846,3213.71%Dec 31, 2023
STATE STREET INSTITUTIONAL INVESTMENT TRUST0.00%359,90021,9006.48%Dec 31, 2023
FIDELITY MT VERNON STREET TRUST0.00%113,244--Feb 29, 2024
OHIO NATIONAL FUND INC0.00%72,34015,26026.73%Dec 31, 2023
NORTHWESTERN MUTUAL SERIES FUND INC0.00%382,380-3,564-0.92%Dec 31, 2023
DEUTSCHE DWS INVESTMENTS VIT FUNDS0.00%1,192--Dec 31, 2023
PIMCO Equity Series0.00%744,910231,79045.17%Dec 31, 2023
EQ ADVISORS TRUST0.00%2,811,736--Dec 31, 2023
FIDELITY CAPITAL TRUST0.00%24,710--Jan 31, 2024
SEASONS SERIES TRUST0.00%47,372-2,529-5.07%Dec 31, 2023
VARIABLE INSURANCE PRODUCTS FUND III0.00%17,000--Dec 31, 2023
VANGUARD INDEX FUNDS0.00%857,079217,20533.94%Dec 31, 2023
QUANTITATIVE MASTER SERIES LLC0.00%11,795--Dec 31, 2023
Blackstone Alternative Investment Funds0.00%221,90010,8005.12%Dec 31, 2023
BNY Mellon ETF Trust0.00%38,916--Feb 29, 2024
RBB FUND, INC.0.00%116,434--Feb 29, 2024
AMERICAN CENTURY ETF TRUST0.00%134,330--Feb 29, 2024
NATIONWIDE VARIABLE INSURANCE TRUST0.00%155,833-98-0.06%Dec 31, 2023
RYDEX DYNAMIC FUNDS0.00%4,526-15-0.33%Dec 31, 2023
WisdomTree Trust0.00%1,737,921--Feb 29, 2024
LINCOLN VARIABLE INSURANCE PRODUCTS TRUST0.00%1,154,18537,0003.31%Dec 31, 2023
EMPOWER FUNDS, INC.0.00%719,673-73,458-9.26%Dec 31, 2023
SPDR SERIES TRUST0.00%17,311,719146,1260.85%Dec 31, 2023
WILMINGTON FUNDS0.00%4,885--Jan 31, 2024
PACE SELECT ADVISORS TRUST0.00%127,870--Jan 31, 2024
Calvert Variable Products, Inc.0.00%641--Dec 31, 2023
Voya VARIABLE PORTFOLIOS INC0.00%6,691--Dec 31, 2023
VANGUARD INSTITUTIONAL INDEX FUNDS0.00%5,209--Dec 31, 2023
NATIONWIDE MUTUAL FUNDS0.00%22,834--Jan 31, 2024
Brighthouse Funds Trust II0.00%337,829--Dec 31, 2023
FIDELITY ADVISOR SERIES I0.00%24,359--Feb 29, 2024
PACIFIC SELECT FUND0.00%408,672-14,854-3.51%Dec 31, 2023
STATE STREET VARIABLE INSURANCE SERIES FUNDS INC0.00%470--Dec 31, 2023
FIDELITY SALEM STREET TRUST0.00%145,559--Feb 29, 2024
Bridge Builder Trust0.00%415,482-326,600-44.01%Dec 31, 2023
TIAA-CREF LIFE FUNDS0.00%146--Dec 31, 2023
STATE STREET INSTITUTIONAL INVESTMENT TRUST0.00%4,100--Dec 31, 2023
ProFunds0.00%399--Jan 31, 2024
COLUMBIA FUNDS SERIES TRUST I0.00%197,611--Feb 29, 2024
T. Rowe Price Index Trust, Inc.0.00%629--Feb 29, 2024
BlackRock Variable Series Funds, Inc.0.00%134,069--Dec 31, 2023
VANGUARD SCOTTSDALE FUNDS0.00%61,891--Feb 29, 2024
NATIONWIDE VARIABLE INSURANCE TRUST0.00%3,754--Dec 31, 2023
VALIC Co I0.00%6,923--Feb 29, 2024
SPDR INDEX SHARES FUNDS0.00%4,356360.83%Dec 31, 2023
RYDEX SERIES FUNDS0.00%77--Dec 31, 2023
Mercer Funds0.00%125,300--Mar 31, 2024
NORTHERN FUNDS0.00%11,066--Dec 29, 2023
RYDEX DYNAMIC FUNDS0.00%48--Dec 31, 2023
PROSHARES TRUST0.00%2,978--Feb 29, 2024
Dimensional ETF Trust0.00%4,950--Jan 31, 2024
PENN SERIES FUNDS INC0.00%300--Dec 29, 2023
HARTFORD MUTUAL FUNDS INC/CT0.00%74,330--Jan 31, 2024
ALLSPRING MASTER TRUST0.00%573--Feb 29, 2024
RYDEX VARIABLE TRUST0.00%9--Dec 31, 2023
LINCOLN VARIABLE INSURANCE PRODUCTS TRUST0.00%16,100--Dec 31, 2023
SEI INSTITUTIONAL MANAGED TRUST0.00%18,871--Dec 31, 2023
SUNAMERICA SERIES TRUST0.00%2,059--Jan 31, 2024
PRUDENTIAL INVESTMENT PORTFOLIOS 20.00%1,141--Jan 31, 2024
DFA INVESTMENT DIMENSIONS GROUP INC0.00%5,017--Jan 31, 2024
COLLEGE RETIREMENT EQUITIES FUND0.00%5,402--Dec 31, 2023
EQ ADVISORS TRUST0.00%4,868791.65%Dec 31, 2023
iSHARES TRUST0.00%64,109--Feb 29, 2024
MORGAN STANLEY PATHWAY FUNDS0.00%253--Feb 29, 2024
MASSMUTUAL SELECT FUNDS0.00%1,627--Dec 31, 2023
PACIFIC SELECT FUND0.00%4,145--Dec 31, 2023
Bridge Builder Trust0.00%4,473--Dec 31, 2023
Meeder Funds0.00%3--Mar 31, 2024
PRINCIPAL FUNDS, INC.0.00%2,592--Feb 29, 2024
BLACKROCK FUNDS0.00%2,314--Feb 29, 2024

Cyteir Therapeutics's largest mutual fund holder by % of total assets is "VANGUARD VALLEY FORGE FUNDS", owning 696.19K shares, compromising 1.42% of its total assets.

Cyteir Therapeutics Institutional Ownership Trends


Institutional Holdings Trend

DateHoldingsChange %
31 Mar, 23326.67%
31 Dec, 2230-16.67%
30 Sep, 2236-10.00%
30 Jun, 2240-20.00%
31 Mar, 22504.17%
31 Dec, 214826.32%
30 Sep, 213818.75%
30 Jun, 2132-
31 Dec, 20--100.00%
30 Sep, 201-
30 Jun, 201-
31 Mar, 201-
31 Dec, 191-
30 Sep, 191-
30 Jun, 191-
31 Mar, 17--
30 Jun, 16--100.00%
31 Mar, 161-
31 Dec, 15--100.00%
30 Sep, 152620.77%
30 Jun, 152603.59%
31 Mar, 15251-3.46%
31 Dec, 142600.78%
30 Sep, 1425813.66%
30 Jun, 142273.18%
31 Mar, 14220-2.65%
31 Dec, 132261514.29%

As of 31 Mar 23, 32 institutions are holding Cyteir Therapeutics's shares, representing an increase of 6.67% compared to the previous quarter.

Shares Outstanding Trend

DateShares OutstandingChange %
31 Mar, 2320,239,636-0.95%
31 Dec, 2220,434,585-3.37%
30 Sep, 2221,146,877-4.64%
30 Jun, 2222,176,521-0.16%
31 Mar, 2222,212,031-0.59%
31 Dec, 2122,344,75613.63%
30 Sep, 2119,664,77618.51%
30 Jun, 2116,593,322-
31 Dec, 20--100.00%
30 Sep, 203,183,697-
30 Jun, 203,183,697-
31 Mar, 203,183,697-
31 Dec, 193,183,697-
30 Sep, 193,183,697-
30 Jun, 193,183,697-
31 Mar, 17--
30 Jun, 16--100.00%
31 Mar, 16940-
31 Dec, 15--100.00%
30 Sep, 1562,779,315-2.80%
30 Jun, 1564,589,7621.87%
31 Mar, 1563,403,7820.91%
31 Dec, 1462,831,915-2.45%
30 Sep, 1464,412,13896.79%
30 Jun, 1432,732,1330.32%
31 Mar, 1432,626,7160.38%
31 Dec, 1332,503,8772949.73%

Cyteir Therapeutics (CYT) has 20.24M shares outstanding as of 31 Mar 23, down -0.95% compared to the previous quarter.

Institutional Ownership Trend

DateOwnership %Change %
31 Mar, 2357.38%-0.80%
31 Dec, 2257.84%-3.50%
30 Sep, 2259.94%-4.75%
30 Jun, 2262.93%-37.07%
31 Mar, 22100.00%56.92%
31 Dec, 2163.73%-36.27%
30 Sep, 21100.00%-
30 Jun, 21100.00%-
31 Dec, 20--100.00%
30 Sep, 20100.00%-
30 Jun, 20--
31 Mar, 20--
31 Dec, 19--
30 Sep, 19--
30 Jun, 19--
31 Mar, 17--
30 Jun, 16--
31 Mar, 16--
31 Dec, 15--
30 Sep, 15--
30 Jun, 15--
31 Mar, 15--
31 Dec, 14--
30 Sep, 14--
30 Jun, 14--
31 Mar, 14--
31 Dec, 13--

As of 31 Mar 23, Cyteir Therapeutics is held by 57.38% institutional shareholders, representing a -0.80% negative growth compared to 31 Dec 22.

Institutional Increased Positions Trend

DateIncreased PositionsChange %
31 Mar, 236-
31 Dec, 226-33.33%
30 Sep, 22912.50%
30 Jun, 228-61.90%
31 Mar, 222131.25%
31 Dec, 211660.00%
30 Sep, 2110-
30 Jun, 21--
31 Dec, 20--
30 Sep, 20--
30 Jun, 20--
31 Mar, 20--
31 Dec, 19--
30 Sep, 19--
30 Jun, 19--
31 Mar, 17--
30 Jun, 16--
31 Mar, 16--
31 Dec, 15--100.00%
30 Sep, 1566-15.38%
30 Jun, 1578-8.24%
31 Mar, 1585-9.57%
31 Dec, 1494-52.76%
30 Sep, 14199180.28%
30 Jun, 1471-14.46%
31 Mar, 14832666.67%
31 Dec, 133200.00%

6 institutional shareholders have increased their position in CYT stock as of 31 Mar 23 compared to 6 in the previous quarter (a 0.00% increase).

Institutional Reduced Positions Trend

DateReduced PositionsChange %
31 Mar, 238-33.33%
31 Dec, 2212-14.29%
30 Sep, 22147.69%
30 Jun, 221344.44%
31 Mar, 229-
31 Dec, 21950.00%
30 Sep, 216-
30 Jun, 21--
31 Dec, 20--
30 Sep, 20--
30 Jun, 20--
31 Mar, 20--
31 Dec, 19--
30 Sep, 19--
30 Jun, 19--
31 Mar, 17--
30 Jun, 16--
31 Mar, 16--
31 Dec, 15--100.00%
30 Sep, 1590-10.00%
30 Jun, 151003.09%
31 Mar, 15973.19%
31 Dec, 1494623.08%
30 Sep, 1413-84.88%
30 Jun, 148614.67%
31 Mar, 14752400.00%
31 Dec, 133-50.00%

8 institutional shareholders have reduced their position in CYT stock as of 31 Mar 23 compared to 12 in the previous quarter (a -33.33% decrease).

All Institutional Ownership Trend Data

DateHoldingsChange %Shares OutstandingChange %Ownership %Change %Increased PositionsChange %Reduced PositionsChange %
31 Mar, 23326.67%20,239,636-0.95%57.38%-0.80%6-8-33.33%
31 Dec, 2230-16.67%20,434,585-3.37%57.84%-3.50%6-33.33%12-14.29%
30 Sep, 2236-10.00%21,146,877-4.64%59.94%-4.75%912.50%147.69%
30 Jun, 2240-20.00%22,176,521-0.16%62.93%-37.07%8-61.90%1344.44%
31 Mar, 22504.17%22,212,031-0.59%100.00%56.92%2131.25%9-
31 Dec, 214826.32%22,344,75613.63%63.73%-36.27%1660.00%950.00%
30 Sep, 213818.75%19,664,77618.51%100.00%-10-6-
30 Jun, 2132-16,593,322-100.00%-----
31 Dec, 20--100.00%--100.00%--100.00%----
30 Sep, 201-3,183,697-100.00%-----
30 Jun, 201-3,183,697-------
31 Mar, 201-3,183,697-------
31 Dec, 191-3,183,697-------
30 Sep, 191-3,183,697-------
30 Jun, 191-3,183,697-------
31 Mar, 17----------
30 Jun, 16--100.00%--100.00%------
31 Mar, 161-940-------
31 Dec, 15--100.00%--100.00%----100.00%--100.00%
30 Sep, 152620.77%62,779,315-2.80%--66-15.38%90-10.00%
30 Jun, 152603.59%64,589,7621.87%--78-8.24%1003.09%
31 Mar, 15251-3.46%63,403,7820.91%--85-9.57%973.19%
31 Dec, 142600.78%62,831,915-2.45%--94-52.76%94623.08%
30 Sep, 1425813.66%64,412,13896.79%--199180.28%13-84.88%
30 Jun, 142273.18%32,732,1330.32%--71-14.46%8614.67%
31 Mar, 14220-2.65%32,626,7160.38%--832666.67%752400.00%
31 Dec, 132261514.29%32,503,8772949.73%--3200.00%3-50.00%

Cyteir Therapeutics Insider Shareholders Trades


Open Market Insider Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Mar 25, 2024Leonard Braden Michael10 percent owner-P-PurchaseBuy170,589$2.95$503.24K3,654,053
Mar 19, 2024Leonard Braden Michael10 percent owner-P-PurchaseBuy113,777$3.01$342.47K3,483,464

Open Market Insider Buys

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Mar 25, 2024Leonard Braden Michael10 percent owner-P-PurchaseBuy170,589$2.95$503.24K3,654,053
Mar 19, 2024Leonard Braden Michael10 percent owner-P-PurchaseBuy113,777$3.01$342.47K3,483,464

Insider Sells

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Mar 19, 2024Leonard Braden Michael10 percent owner-Sell---335,000
Mar 05, 2024Gaiero David Gofficer Chief Financial OfficerM-ExemptSell4,746$1.69$8.02K85,425
Mar 05, 2024Gaiero David Gofficer Chief Financial OfficerM-ExemptSell2,373$1.69$4.01K83,052
Mar 05, 2024Gaiero David Gofficer Chief Financial OfficerM-ExemptSell3,239$1.68$5.44K16,196
Mar 05, 2024RENSCHLER MARKUS MDdirector, officer President and CEOM-ExemptSell12,607$1.69$21.31K226,952
Mar 05, 2024RENSCHLER MARKUS MDdirector, officer President and CEOM-ExemptSell6,304$1.69$10.65K220,648
Mar 05, 2024RENSCHLER MARKUS MDdirector, officer President and CEOM-ExemptSell2,537$1.20$3.04K-
Feb 16, 2024George Jeandirector-M-ExemptSell14,150$1.69$23.91K-
Feb 14, 2024Sands Stephen H.director-M-ExemptSell12,129$1.69$20.50K-

All Insider Owners Trades

DateNameRelationRoleTransactionBuy/SellSharesPriceValueShares HeldSource
Mar 25, 2024Leonard Braden Michael10 percent owner-P-PurchaseBuy170,589$2.95$503.24K3,654,053
Mar 19, 2024Leonard Braden Michael10 percent owner-P-PurchaseBuy113,777$3.01$342.47K3,483,464
Mar 19, 2024Leonard Braden Michael10 percent owner-Buy---3,369,687
Mar 19, 2024Leonard Braden Michael10 percent owner-Sell---335,000
Mar 05, 2024Gaiero David Gofficer Chief Financial OfficerM-ExemptBuy2,373$1.69$4.01K102,391
Mar 05, 2024Gaiero David Gofficer Chief Financial OfficerM-ExemptBuy4,746$1.69$8.02K100,018
Mar 05, 2024Gaiero David Gofficer Chief Financial OfficerM-ExemptBuy3,239$1.68$5.44K95,272
Mar 05, 2024Gaiero David Gofficer Chief Financial OfficerM-ExemptSell4,746$1.69$8.02K85,425
Mar 05, 2024Gaiero David Gofficer Chief Financial OfficerM-ExemptSell2,373$1.69$4.01K83,052
Mar 05, 2024Gaiero David Gofficer Chief Financial OfficerM-ExemptSell3,239$1.68$5.44K16,196
Mar 05, 2024RENSCHLER MARKUS MDdirector, officer President and CEOM-ExemptBuy6,304$1.69$10.65K1,103,661
Mar 05, 2024RENSCHLER MARKUS MDdirector, officer President and CEOM-ExemptBuy2,537$1.20$3.04K1,097,357
Mar 05, 2024RENSCHLER MARKUS MDdirector, officer President and CEOM-ExemptBuy12,607$1.69$21.31K1,094,820
Mar 05, 2024RENSCHLER MARKUS MDdirector, officer President and CEOM-ExemptSell12,607$1.69$21.31K226,952
Mar 05, 2024RENSCHLER MARKUS MDdirector, officer President and CEOM-ExemptSell6,304$1.69$10.65K220,648
Mar 05, 2024RENSCHLER MARKUS MDdirector, officer President and CEOM-ExemptSell2,537$1.20$3.04K-
Feb 16, 2024George Jeandirector-M-ExemptBuy14,150$1.69$23.91K14,150
Feb 16, 2024George Jeandirector-M-ExemptSell14,150$1.69$23.91K-
Feb 14, 2024Sands Stephen H.director-M-ExemptBuy12,129$1.69$20.50K12,129
Feb 14, 2024Sands Stephen H.director-M-ExemptSell12,129$1.69$20.50K-

The last insider sell of Cyteir Therapeutics's stock was made by Leonard Braden Michael on Mar 19 2024, selling - shares at - per share (valued at -). The last insider buy of CYT was made by Leonard Braden Michael on Mar 25 2024, buying 170,589 shares at $2.95 per share (worth $503.24K).

Cyteir Therapeutics Insider Ownership Trends


All Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q1 20241111100.00%
Q4 202388100.00%
Q3 2023-5-
Q2 2023-12-
Q1 202313--
Q4 202232150.00%
Q3 2022-1-
Q2 20225--
Q1 202213--
Q4 20211311300.00%
Q2 2021113828.95%
Q4 201571070.00%
Q3 20156--
Q2 2015133433.33%
Q1 201598112.50%
Q4 20145--
Q3 20145--
Q2 2014134325.00%
Q1 201474175.00%
Q4 20135--

11 total buy trades, and 11 total sell trades (buy/sell ratio of 1.00%) were made by Cyteir Therapeutics's insiders, as of Q1 2024.

Open Market Insider Trades Trend

DateBuySellBuy/Sell Ratio
Q1 20241--
Q4 2023---
Q3 2023-5-
Q2 2023-12-
Q1 2023---
Q4 20221--
Q3 2022-1-
Q2 20224--
Q1 2022---
Q4 202111--
Q2 20213--
Q4 2015---
Q3 2015---
Q2 2015---
Q1 2015-4-
Q4 2014---
Q3 2014---
Q2 2014---
Q1 2014-2-
Q4 2013---

As of Q1 2024, Insider owners conducted 1 open market buy trades and 0 open market sell trades of Cyteir Therapeutics's stocks.

Cyteir Therapeutics Peer Ownership


TickerCompany
ANEBAnebulo Pharmaceuticals, Inc.
RZLTRezolute, Inc.
NKTXNkarta, Inc.
GBIOGeneration Bio Co.
CCCCC4 Therapeutics, Inc.
FHTXFoghorn Therapeutics Inc.
MGTADianthus Therapeutics, Inc.
NUVBNuvation Bio Inc.
ELYMEliem Therapeutics, Inc.
HCWBHCW Biologics Inc.
PRLDPrelude Therapeutics Incorporated
CSBRChampions Oncology, Inc.
GLUEMonte Rosa Therapeutics, Inc.
GRPHLENZ Therapeutics, Inc.
SANASana Biotechnology, Inc.
LYELLyell Immunopharma, Inc.
MOLNMolecular Partners AG
NLTXNeurogene Inc.
MNOVMediciNova, Inc.

CYT Ownership FAQ


Cyteir Therapeutics is owned by institutional shareholders (57.38%), insiders (6.64%), and public (35.98%). The largest institutional shareholder of Cyteir Therapeutics is NOVO HOLDINGS A/S (11.17% of total shares) and the top mutual fund owner is VANGUARD VALLEY FORGE FUNDS (1.42% of total shares).

Cyteir Therapeutics's major institutional shareholders are NOVO HOLDINGS A/S, PUBLIC EMPLOYEES RETIREMENT SYSTEM OF OHIO, BML CAPITAL MANAGEMENT, LLC, OUP MANAGEMENT CO., LLC, and FMR LLC. The top five shareholders own together 42.48% of the company's share outstanding.

As of Mar 2023, there are 32 institutional shareholders of Cyteir Therapeutics.

NOVO HOLDINGS A/S owns 3.94M shares of Cyteir Therapeutics, representing 11.17% of the company's total shares outstanding, valued at $112.89B (as of Mar 2023).

As of Mar 2023, PUBLIC EMPLOYEES RETIREMENT SYSTEM OF OHIO holds 3.18M shares of Cyteir Therapeutics (CYT), compromising 9.03% of the company, valued at $46K.

BML CAPITAL MANAGEMENT, LLC is the third largest holder of Cyteir Therapeutics. The company owns 3.15M of the company's shares outstanding (worth $5.73B).